US3242186A
(en)
*
|
1960-07-13 |
1966-03-22 |
Polaroid Corp |
2, 5-dihydroxytriptycyl compounds and processes for their syntheses
|
US3259622A
(en)
*
|
1962-09-07 |
1966-07-05 |
Merck & Co Inc |
1-benzyl-3-indolyl-alpha-haloalkyl and alkylidenyl acetic acids
|
US3376316A
(en)
*
|
1962-12-28 |
1968-04-02 |
Merck & Co Inc |
Lower alkyl gamma keto acid 2-pyranyl esters
|
US3306822A
(en)
*
|
1963-05-20 |
1967-02-28 |
Merck & Co Inc |
Anti-inflammatory therapy with 3-indolinyl compounds
|
BE659364A
(xx)
*
|
1964-02-05 |
|
|
|
US3450814A
(en)
*
|
1964-07-15 |
1969-06-17 |
Chemway Corp |
Ophthalmic compositions containing alginic acid salts of pilocarpine,atropine and physostigmine
|
US3271394A
(en)
*
|
1964-12-31 |
1966-09-06 |
Merck & Co Inc |
Alpha-indolyl-3-acetic acid esters
|
US3417096A
(en)
*
|
1965-07-01 |
1968-12-17 |
Bristol Myers Co |
Certain 5(1-benzoyl-3-indolylmethyl) tetrazoles
|
US3397211A
(en)
*
|
1966-09-09 |
1968-08-13 |
Merck & Co Inc |
Process for preparing 3-indolyl acetic acids
|
US3471514A
(en)
*
|
1966-11-14 |
1969-10-07 |
Merck & Co Inc |
Process for alpha-(5-nitroindolyl-3)-alkanoic acids
|
US3468907A
(en)
*
|
1967-04-10 |
1969-09-23 |
Schering Corp |
Glyceryl esters of alpha-(1-aroyl-3-indolyl)alkanoic acids
|
NL6804994A
(xx)
*
|
1967-04-11 |
1968-10-14 |
|
|
US3476770A
(en)
*
|
1967-04-14 |
1969-11-04 |
Parke Davis & Co |
2-methyl-7-phenylindole-3-acetic acid compounds
|
US3501498A
(en)
*
|
1967-07-26 |
1970-03-17 |
Merck & Co Inc |
Nitro- and amino-substituted 1-p-chlorobenzyl-2-methyl-3-indolylacetic acids
|
US3497526A
(en)
*
|
1967-07-26 |
1970-02-24 |
Merck & Co Inc |
Organo-metallic compounds
|
HU162374B
(xx)
*
|
1969-04-03 |
1973-02-28 |
|
|
US3800041A
(en)
*
|
1971-03-02 |
1974-03-26 |
Lilly Co Eli |
Analgesic compositions and methods
|
US3939178A
(en)
*
|
1971-06-01 |
1976-02-17 |
American Home Products Corporation |
Certain pyrano [3,4-b]indoles and thiopyrano[3,4-b]indoles
|
JPS49149723U
(xx)
*
|
1973-04-25 |
1974-12-25 |
|
|
US4029798A
(en)
*
|
1975-06-02 |
1977-06-14 |
Sumitomo Chemical Company, Limited |
Analgetic composition
|
US4119638A
(en)
*
|
1976-11-29 |
1978-10-10 |
G. D. Searle & Co. |
Thio-ester of 1 (p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid
|
DK244179A
(da)
*
|
1978-06-13 |
1979-12-14 |
Merck & Co Inc |
Fremgangsmaade til fremstilling af krystallinsk natrium og kaliumindomethacin og trihydrater deraf
|
US4258185A
(en)
*
|
1978-10-17 |
1981-03-24 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Pyridazinone compounds
|
DE2935776A1
(de)
*
|
1979-09-05 |
1981-04-16 |
Theodor Prof. Dr. 4400 Münster Eckert |
Organische salze des indometacin, des naproxen und des diclofenac, ihre herstellung und sie enthaltende arzneimittel
|
HU185926B
(en)
*
|
1979-09-27 |
1985-04-28 |
Agostne Kahan |
Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
|
DE2943125A1
(de)
*
|
1979-10-25 |
1981-05-14 |
Troponwerke GmbH & Co KG, 5000 Köln |
Verfahren zur herstellung von 1-(4-chlorbenzoyl)-5-methoxy-2-methyl-3-indol acetoxyessigsaeure
|
DE3026402A1
(de)
*
|
1980-07-11 |
1982-02-04 |
Syntex Corp., Palo Alto, Calif. |
Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
|
US4379792A
(en)
*
|
1980-10-30 |
1983-04-12 |
Merck & Co., Inc. |
Anti-inflammatory composition
|
AT370721B
(de)
*
|
1981-02-24 |
1983-04-25 |
Ciba Geigy Ag |
Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
|
LU83138A1
(de)
*
|
1981-02-16 |
1981-09-11 |
T Eckert |
Topische pharmazeutische praeparate,enthaltend salze von alkancarbonsaeuren sowie neue carbonsaeuresalze und verfahren zu ihrer herstellung
|
DE3206885A1
(de)
*
|
1982-02-26 |
1983-09-15 |
Troponwerke GmbH & Co KG, 5000 Köln |
Indolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
US4407804A
(en)
*
|
1982-06-30 |
1983-10-04 |
E. I. Du Pont De Nemours And Company |
Analgesic mixture of nalbuphine and indomethacin
|
US5166141A
(en)
*
|
1983-11-01 |
1992-11-24 |
Scripps Clinic And Research Foundation |
Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
|
DE3431689A1
(de)
*
|
1984-08-29 |
1986-03-13 |
Bayer Ag, 5090 Leverkusen |
Verfahren zur herstellung von 5-acylpyrimidinen
|
JPS61152656A
(ja)
*
|
1984-12-27 |
1986-07-11 |
Taiho Yakuhin Kogyo Kk |
ピペラジン誘導体
|
EP0418597A3
(en)
*
|
1989-09-21 |
1991-11-27 |
American Cyanamid Company |
Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form
|
IL95423A
(en)
*
|
1989-09-21 |
1994-11-11 |
American Cyanamid Co |
Pulse system for delivery of minocycline once daily
|
AU655762B2
(en)
*
|
1989-12-26 |
1995-01-12 |
Nova Pharmaceutical Corporation |
Prodrug anhydrides of asprin, indomethacin and ibuprofen, their preparation, compositions, and anti-inflammatory method of use
|
AU658373B2
(en)
*
|
1990-11-06 |
1995-04-13 |
Fgn, Inc. |
Esters and amides of substituted pyrrole acetic acids
|
JP2552950B2
(ja)
*
|
1990-11-13 |
1996-11-13 |
信越化学工業株式会社 |
アルコキシシランの製造方法
|
US5401774A
(en)
*
|
1991-03-08 |
1995-03-28 |
University Of Arizona |
Method for treating patients with precancerous lesions by administering substituted sulfonyl idenyl acetic and propionic acids and esters to patients with lesions sensitive to such compounds
|
DE69202721T2
(de)
*
|
1991-03-08 |
1995-10-12 |
Fgn Inc |
Substituierte Indenylverbindungen.
|
US5143927A
(en)
*
|
1991-05-09 |
1992-09-01 |
Warner-Lambert Company |
3-(thiazolidone, oxazolidinone, imidazolidinone)-indoles as antiinflammatory agents
|
US5250552A
(en)
*
|
1991-05-09 |
1993-10-05 |
Warner-Lambert Company |
3-[thiazolidinone, oxazolidinone, imidazolidinone]-indoles as antiinflammatory agents
|
US5124347A
(en)
*
|
1991-07-31 |
1992-06-23 |
Warner-Lambert Co. |
3-5-ditertiarybutylphenyl-4-hydroxymethylidene derivatives of 1,3-dihydro-2H-indole-2-ones as antiinflammatory agents
|
US5463083A
(en)
|
1992-07-13 |
1995-10-31 |
Cytomed, Inc. |
Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
|
US5436265A
(en)
*
|
1993-11-12 |
1995-07-25 |
Merck Frosst Canada, Inc. |
1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents
|
US5776962A
(en)
*
|
1994-08-03 |
1998-07-07 |
Cell Pathways, Inc. |
Lactone compounds for treating patient with precancerous lesions
|
US5696159A
(en)
*
|
1994-08-03 |
1997-12-09 |
Cell Pathways, Inc. |
Lactone compounds for treating patients with precancerous lesions
|
US5484940A
(en)
*
|
1994-11-28 |
1996-01-16 |
Grant; Francine S. |
Substituted 3-indolyl-5-pyrazolone compounds
|
US5532237A
(en)
*
|
1995-02-15 |
1996-07-02 |
Merck Frosst Canada, Inc. |
Indole derivatives with affinity for the cannabinoid receptor
|
US5604253A
(en)
*
|
1995-05-22 |
1997-02-18 |
Merck Frosst Canada, Inc. |
N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors
|
US5510368A
(en)
*
|
1995-05-22 |
1996-04-23 |
Merck Frosst Canada, Inc. |
N-benzyl-3-indoleacetic acids as antiinflammatory drugs
|
US5639780A
(en)
*
|
1995-05-22 |
1997-06-17 |
Merck Frosst Canada, Inc. |
N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
|
US5874440A
(en)
*
|
1995-06-07 |
1999-02-23 |
Cell Pathways, Inc. |
Method of treating a patient having precancerous lesions with phenyl pyrimidinone derivatives
|
US6046206A
(en)
*
|
1995-06-07 |
2000-04-04 |
Cell Pathways, Inc. |
Method of treating a patient having a precancerous lesions with amide quinazoline derivatives
|
US6060477A
(en)
*
|
1995-06-07 |
2000-05-09 |
Cell Pathways, Inc. |
Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives
|
US6232312B1
(en)
|
1995-06-07 |
2001-05-15 |
Cell Pathways, Inc. |
Method for treating patient having precancerous lesions with a combination of pyrimidopyrimidine derivatives and esters and amides of substituted indenyl acetic acides
|
US6262059B1
(en)
|
1995-06-07 |
2001-07-17 |
Cell Pathways, Inc. |
Method of treating a patient having precancerous lesions with quinazoline derivatives
|
US6200980B1
(en)
|
1995-06-07 |
2001-03-13 |
Cell Pathways, Inc. |
Method of treating a patient having precancerous lesions with phenyl purinone derivatives
|
US6046216A
(en)
*
|
1995-06-07 |
2000-04-04 |
Cell Pathways, Inc. |
Method of treating a patient having precancerous lesions with phenyl pyridinone derivatives
|
US5998477A
(en)
*
|
1996-06-13 |
1999-12-07 |
Cell Pathways Inc. |
Substituted methoxy benzylidene indenyl-acetic and propionic acids for treating patients with precancerous lesions
|
US5965619A
(en)
*
|
1996-06-13 |
1999-10-12 |
Cell Pathways Inc. |
Method for treating patients having precancerous lesions with substituted indene derivatives
|
US6063818A
(en)
*
|
1996-06-13 |
2000-05-16 |
Cell Pathways Inc. |
Substituted benzylidene indenyl formamides, acetamides and propionamides
|
IT1288123B1
(it)
*
|
1996-09-04 |
1998-09-10 |
Nicox Sa |
Uso di nitroderivati per l'incontinenza urinaria
|
US5858694A
(en)
*
|
1997-05-30 |
1999-01-12 |
Cell Pathways, Inc. |
Method for identifying compounds for inhibition of cancerous lesions
|
CA2238283C
(en)
*
|
1997-05-30 |
2002-08-20 |
Cell Pathways, Inc. |
Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions
|
US6103765A
(en)
*
|
1997-07-09 |
2000-08-15 |
Androsolutions, Inc. |
Methods for treating male erectile dysfunction
|
CA2295595A1
(en)
|
1997-07-09 |
1999-01-21 |
Androsolutions, Inc. |
Improved methods and compositions for treating male erectile dysfunction
|
US5852035A
(en)
*
|
1997-12-12 |
1998-12-22 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines
|
US5948779A
(en)
*
|
1997-12-12 |
1999-09-07 |
Cell Pathways, Inc. |
Substituted condensation products of n-benzyl-3-indenyl acetamides with heterocyclic aldehydes
|
US6046199A
(en)
*
|
1998-01-14 |
2000-04-04 |
Cell Pathways, Inc. |
Method of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B]indole derivatives
|
US6410584B1
(en)
*
|
1998-01-14 |
2002-06-25 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells with indole derivatives
|
US5942520A
(en)
*
|
1998-01-27 |
1999-08-24 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 amines
|
US6028116A
(en)
*
|
1998-04-03 |
2000-02-22 |
Cell Pathways, Inc. |
Substituted condensation products of 1H-indenyl-hydroxyalkanes with aldehydes for neoplasia
|
US5990117A
(en)
*
|
1998-04-15 |
1999-11-23 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells and related conditions by exposure to quinazoline derivatives
|
US6268372B1
(en)
|
1998-09-11 |
2001-07-31 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones
|
US6124303A
(en)
*
|
1998-09-11 |
2000-09-26 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones
|
US6130053A
(en)
*
|
1999-08-03 |
2000-10-10 |
Cell Pathways, Inc. |
Method for selecting compounds for inhibition of neoplastic lesions
|
US6200771B1
(en)
|
1998-10-15 |
2001-03-13 |
Cell Pathways, Inc. |
Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia
|
US6133271A
(en)
*
|
1998-11-19 |
2000-10-17 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
|
US6187779B1
(en)
|
1998-11-20 |
2001-02-13 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives
|
US6369092B1
(en)
|
1998-11-23 |
2002-04-09 |
Cell Pathways, Inc. |
Method for treating neoplasia by exposure to substituted benzimidazole derivatives
|
US6034099A
(en)
*
|
1998-11-24 |
2000-03-07 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones
|
US6486155B1
(en)
|
1998-11-24 |
2002-11-26 |
Cell Pathways Inc |
Method of inhibiting neoplastic cells with isoquinoline derivatives
|
US6077842A
(en)
*
|
1998-11-24 |
2000-06-20 |
Cell Pathways, Inc. |
Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives
|
US6207700B1
(en)
|
1999-01-07 |
2001-03-27 |
Vanderbilt University |
Amide derivatives for antiangiogenic and/or antitumorigenic use
|
US6762182B1
(en)
|
1999-01-07 |
2004-07-13 |
Vanderbilt University |
Converting cox inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors
|
US6025394A
(en)
|
1999-01-29 |
2000-02-15 |
Cell Pathways, Inc. |
Method for treating patients with acne by administering substituted sulfonyl indenyl acetic acids, amides and alcohols
|
US6020379A
(en)
*
|
1999-02-19 |
2000-02-01 |
Cell Pathways, Inc. |
Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia
|
IT1308633B1
(it)
|
1999-03-02 |
2002-01-09 |
Nicox Sa |
Nitrossiderivati.
|
DE10006139A1
(de)
*
|
2000-02-11 |
2001-08-16 |
Merck Patent Gmbh |
Indol-3-yl-Derivate
|
US6555547B1
(en)
|
2000-02-28 |
2003-04-29 |
Cell Pathways, Inc. |
Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative
|
US6569638B1
(en)
|
2000-03-03 |
2003-05-27 |
Cell Pathways, Inc |
Method for screening compounds for the treatment of neoplasia
|
DE60102461T2
(de)
*
|
2000-04-27 |
2005-02-24 |
Basilea Pharmaceutica Ag |
Pyrimidinyl methyl indolderivate mit antibakterieller wirkung
|
IT1318673B1
(it)
*
|
2000-08-08 |
2003-08-27 |
Nicox Sa |
Farmaci per le disfunzioni sessuali.
|
IT1318674B1
(it)
*
|
2000-08-08 |
2003-08-27 |
Nicox Sa |
Faramaci per l'incontinenza.
|
US6544556B1
(en)
|
2000-09-11 |
2003-04-08 |
Andrx Corporation |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
|
WO2002069968A1
(en)
*
|
2001-03-08 |
2002-09-12 |
Astrazeneca Ab |
New use
|
US6479493B1
(en)
|
2001-08-23 |
2002-11-12 |
Cell Pathways, Inc. |
Methods for treatment of type I diabetes
|
JPWO2003022814A1
(ja)
*
|
2001-09-07 |
2004-12-24 |
小野薬品工業株式会社 |
インドール誘導体化合物
|
ITMI20020773A1
(it)
*
|
2002-04-11 |
2003-10-13 |
Nicox Sa |
Farmaci per il trattamento dell'artrite
|
CN1791402A
(zh)
*
|
2003-03-27 |
2006-06-21 |
麦克公司 |
治疗眼高压的眼科组合物
|
US20050002859A1
(en)
*
|
2003-06-25 |
2005-01-06 |
Vanderbilt University |
COX-2-targeted imaging agents
|
WO2005002525A2
(en)
*
|
2003-07-01 |
2005-01-13 |
Microbia, Inc. |
Cox-2 and faah inhibitors
|
ITRM20030394A1
(it)
|
2003-08-12 |
2005-02-13 |
Maria Gabriella Santoro |
Uso dell'indometacina e derivati come farmaci antivirali e relative composizioni farmaceutiche.
|
CA2562783A1
(en)
*
|
2004-04-26 |
2005-12-01 |
Vanderbilt University |
Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity
|
KR20070100269A
(ko)
*
|
2005-01-04 |
2007-10-10 |
노파르티스 아게 |
인간 fpps의 x-선 구조 및 fpps 결합 화합물의선별을 위한 용도
|
KR20080091134A
(ko)
*
|
2006-01-04 |
2008-10-09 |
써던 리서취 인스티튜트 |
술린닥의 유도체,이의 용도 및 제조방법
|
AU2007223787A1
(en)
|
2006-03-08 |
2007-09-13 |
Pharmena North America Inc. |
Combination therapy with non-selective COX inhibitors to prevent COX-related gastric injuries
|
EP2040699A4
(en)
|
2006-06-19 |
2013-03-13 |
Vanderbilt University Medical Ct |
METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND THERAPEUTIC TARGETING OF COX-2
|
JP5201660B2
(ja)
*
|
2007-12-27 |
2013-06-05 |
独立行政法人産業技術総合研究所 |
4−トリフルオロメチルインドール−3−酢酸
|
CN102924352B
(zh)
*
|
2011-08-10 |
2013-11-20 |
北京英力科技发展有限公司 |
一种合成4-巯基苯甲酸酯的方法
|
EP2768499A4
(en)
|
2011-10-17 |
2015-08-26 |
Univ Vanderbilt |
INDOMETACIN ANALOGUES FOR THE TREATMENT OF CANCER PROSTATE RESISTANT TO CASTRATION
|
CN102827030B
(zh)
*
|
2012-09-24 |
2014-05-07 |
复旦大学 |
一种 (3r, 5r)-3, 5-二羟基-6-氰基己酸酯的制备方法
|